Hantz Financial Services Inc. Grows Position in Haleon plc (NYSE:HLN)

Hantz Financial Services Inc. increased its position in shares of Haleon plc (NYSE:HLN) by 43.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 604,946 shares of the company’s stock after buying an additional 182,015 shares during the quarter. Hantz Financial Services Inc.’s holdings in Haleon were worth $5,771,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Fortitude Family Office LLC purchased a new position in shares of Haleon in the 3rd quarter valued at approximately $28,000. Versant Capital Management Inc grew its stake in shares of Haleon by 2,029.1% in the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after purchasing an additional 3,348 shares during the last quarter. Geneos Wealth Management Inc. purchased a new position in shares of Haleon in the 4th quarter valued at approximately $35,000. Toronto Dominion Bank grew its stake in shares of Haleon by 3,470.0% in the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after purchasing an additional 3,470 shares during the last quarter. Finally, Prospera Private Wealth LLC purchased a new position in shares of Haleon in the 3rd quarter valued at approximately $57,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on HLN. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Stock Performance

Shares of HLN stock opened at $9.53 on Thursday. The stock has a fifty day moving average price of $9.54 and a 200 day moving average price of $9.75. The stock has a market cap of $43.12 billion, a PE ratio of 28.01, a P/E/G ratio of 2.60 and a beta of 0.29. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Haleon (NYSE:HLN) last issued its quarterly earnings data on Thursday, October 31st. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.03. The firm had revenue of $3.62 billion during the quarter, compared to analysts’ expectations of $3.74 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. During the same period in the previous year, the firm posted $0.10 earnings per share. Sell-side analysts forecast that Haleon plc will post 0.44 earnings per share for the current fiscal year.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.